New research reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Experts urge combining medication with lasting lifestyle changes for effective long-term ...

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.